ArticleBriefings in functional genomics2026
Multi-view knowledge-guided flow subgraphs with substructure initialization for explainable DDI prediction.
Article in Briefings in functional genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polypharmacy has become essential in managing complex and chronic conditions, yet it introduces significant clinical risks due to potential drug-drug interactions (DDIs). Existing computational models struggle to provide accurate and interpretable predictions, largely due to fragmented integration of molecular structures and biomedical knowledge. These limitations arise from static graph designs, inadequate substructure modeling, and insufficient incorporation of semantic context, highlighting the need for a unified, explainable solution. In this study, we propose MKGFlow-DDI, a multi-view knowledge-guided framework that jointly leverages drug-drug interaction networks and biomedical knowledge graphs to dynamically construct drug-flow subgraphs. The model incorporates a dual-channel encoder designed to capture atom-level information and substructure-level features, integrating them with the global semantic embeddings of the composite network to derive novel feature representations. These representations are fused to initialize node features within each subgraph, which are iteratively optimized through similarity-based edge refinement to reduce noise and enhance biological relevance. To further improve generalization and stability, a contrastive learning module is introduced to align representations of perturbed subgraphs by maximizing consistency across positive and negative sample pairs. Experimental results on DrugBank and TWOSIDES demonstrate that MKGFlow-DDI outperforms state-of-the-art baselines, especially in scenarios involving previously unseen drugs. Additionally, the model produces interpretable semantic pathways that align with known pharmacological mechanisms, enabling clinically meaningful insights. Overall, MKGFlow-DDI establishes a robust and biologically grounded approach to DDI prediction, offering a promising direction for computational pharmacovigilance and personalized therapy optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.